Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A p/r presenting any impact on TPIV from Sunday's U.S. NCI release at the American Society of Clinical Oncology conference.
Last week high was $7.01, now $4.45, a drop of nearly 40%... no board comments?
This is more than profit taking, looking back at daily volumes... it would be responsible to view a company pr, in my opinion.
Dave... I completely agree... this Friday an anticipated bill signing?... I didn't know this... if done, think of how many would have new hope for a possible cure, rather than dispair.
TAP and MARKER THERAPUTICS merger presentation of details is good and in need of repetition in various other venues.
What some of us would like to know is: how important is the TPIV clinical pipeline compared to M.T? .. When will we receive TPIV results?.. What are near term milestones? Have you received accurate advice on how to increase snd support share price, both before the next round of needed financing and company valuation?
I hope to get message board and company feed back beyond " hope and wishes."
PL... soothing, invigorating, hopeful words... thank you... stay with us...
Someday. Many of us will meet up and enjoy a many day meeting of relaxation.
Thanks again... a 'long' here.... past, present, and future.
Gatta..
P/Lord... well done, well reported. The CEO appropriately suggests a good to great outcome in time ( unknown). We either believe and hold, believe and buy, or doubt and sell.
I can only hope that he will get the share price above $5.00, $7.00 being better before having to issue more shares. The current and dropping price is nerve wracking.... everyone is losing big time.
Myself..down $200,000+.. last few days sleeping less.. no advice needed.
I wonder where RK Matters of 2915/16 are?
P/L.... thank you again... stay nearby, please, and all you other good posters.
Please ask.. given the reported success thus far, comparing to similar science, why is it that the market cap is so low and what will it take to bring fair market value? Est. FMV...$300 million.
At this successful stage of development and results, I suggest the share value should rise close to $40 based on the above and insignificant number of shares.
Which Pharma company will be first to bid for the company, not wishing to be left in the dust..... because this vaccine will be in high demand by women world wide as news circulates. Remember, also their other ' off the shelf ' base vaccines.
When you listen to the president of the U.S. speak to the issue of " right to try " and is asking Congress to pass legislation, how would this affect the clinical trials, Fast track, and hoped for positive immune results?
Think it through and offer your opinion.
I am holding 45,000 shares bought over a lengthy period of time. I intend to acquire 5,000 more by the end of February. I intend to wait for $50.00 a share and then closely examine the opportunistic business landscape. Quite a few interesting science posts here, and a few " off the wall" remarks. GLTA.
I do and will continue to have active contact with company regardless of their response. Every organization takes due notice when activist shareholders are sending their concerns. To just " wallow" on any message board, is non productive, rather, just " pot stirring "
One hundred e-mails versus one... obvious, isn't it?
It ought to be obvious that every concerned shareholder should be constantly contacting the company demanding a progress report, NOW!
This report and board member amplification is favorable news from the science world.
How will this translate in the real world of treatment, and how/ when will it favorably translate in the investment world. My small 40,000 shares keep asking me for answers.
Aside from the pleasantries with most posts here, a reality is sought.... do the clinical trials work.. yes or no.
Answer will either come from milestones promises for 3rd quarter or from demanding accurate responses at the shareholder meeting.
Everyth8ng else is opionated speculation which has been worthless.
Only management knows what is true and they are not supporting the shareholders ( owners ) investment.
Low volumes.. likely, selling by disappointed and disenchanted long shareholders...giv8ng up on a lack of significant news..
I hope that news dies come soon.
Thanks Phantom.
Phantom, always good to read your balanced posts... what and and many would like to know is... does anyone contact the company and ASK for results that they promised? Also, many woyld like to know if RKmatters, Blu , and others of the past are still in or were all those posts a shill game?
I am 40k deep in shares, and now based on a lack of reporting of significant results, p1 and initial p2, even I am getting concerned whether positive results are happening.
I always remember that the shareholders are the real owners of a public company. Maybe there ought to have happen a shareholder meeting.
Burr, it is...and committed...and nerves of steel.
I bought 3k today. Now holding 37,000 and deeply trusting that TPIV will not only report quarterly results, but more importantly, good results in the vaccine p/1 and solid p/2 progress
When a company decides to remain quiet, it either has great confidence in its operations or there is a concern. I trust the former because it would be required to report on the latter.
$10 a share would be a solid value start, imo. My target remains $50.00.
GLTA.. seriously.
TPIV management doesn't seem to care about the shareholders, who in fact are both the company owners and the ultimate directors of management. The share price has dropped from near $7.00 to the low $4.00's without any meaningful attempts to support the share price. This is close to a 40% drop resulting from the Reverse 1for 12 share split, which I would remind you that there were several posters who stated this would never happen and they looked soon for above $20.00 per share.
Management is separated from the two progressing trials held by Mayo and S/K Astra.
They ought to be able to relay any and all positives, but the trend for the past many months is the opposite, P/R quiet. Not good, my friends. Yes, I am down over $100,000 and if I could get to break even, honestly like many here I would lighten up or run for the hills.
Remember up to last May or so when the posters were constantly touting the science and break throughs? Where are they now... RK , Blu, TPZZZ..?
Sobering thoughts of losses and concerns about positive outcomes now are present and the sellIng continues.
E-mails to management are the only activism available to any and all of us.
Dead money awaiting the years 2017, 2018 is not an investment. If we had something great, there would be buy out offers on the table.
Ahhhhhh, my six posts versus your 716 posts. Interesting .
I like the way you wiggle in insults when ever their is a cogent argument presented.
I have over $210,000 invested. I don't know your total, nor do I care.
I have great hopes for the science and application, but this is an investment and we, perhaps other than you, have a vested interest in communications to us from the company and regarding Uplisting, a strategy of good releases for the viewing public and investment houses back rooms.
Therefore, since I can not get you to look st the business and investment issues, please continue with the soft cheerleading.... and hit the 1,000 post level soon.
.... And this from the board "director of opinions". No thanks.
Price has eroded over the trailing 12 months. Real clinical data has not been forth coming.
Releases on capital share structure is only one thing: dilutive.
Months ago, this board had prominent posters the likes of RK, Blu, and Tp. Data and science. Now, look by posting comparison... Soft cheerleading.
I do effective DD but there is a dearth of data from this newly formed or expanded management group.
Something lost, unknown what is gained at this very point in time.
Uplisting will take place, mostly because outside agents have the responsibility to accomplish it.
However, I have become very disappointed with the companies transparency and a lack of effective communication to shareholders and the public comparing these past six months with the previous six or more months. They have failed me as an investor.
I realize that my 24,000 shares has become not only " dead money ", but eroding investment capital.
Each time there has been a Reverse Split, the issuance of new shares, and issuance of warrants, the ownership of the company is growing in the hands of a small group, and we who were more prominent are now minor stake holders. Even though illegal, I do suspect that the bigger hands have more insight then any on this board.
The company needs to issue updates. If a trial timeline was changed or missed, that is significant to me.
In short, I am an owner among others and I want to know what my company is doing, both operationally and financially.
The mild board cheerleaders here, offer no details, no specifics, just tranquilizing words and opinions.
We ought to expect more. In the last analysis, this is business and not a club house.
Well.... I'd like to say " I feel better now" , but can't. Thanks for reading.
I have a solid inquiry of the board.
* Fact, the share price over this year is down trending, ending today at.$0.45.
* The company has not released and information of value to shareholders who, because it is a public company, are the owners.
* Dilution of ownership has taken place several times and if you were in at the beginning, you have significant losses.
* A R/S will further dilute your position in the future because the company will have the opportunity based in lower shares to issue more stock and warrants.
* A R/S usually tracks slightly higher and then drops 15%.
* Because the company does nothing to support the share price, I am certain that short sellers will drive this down from above $5.00 to well below $5.00 and then begins the issue of remaining on the uplifted exchange.
* Months ago there were solid dominant posters on this bo, among them: RK matters, TPazzzzz, Blu, and a few confident others. Their reduction in posting or cessation has made some investors uneasy and others, newer posters to become dominant, with mostly cheeleading emotion or simple opinion. This is a considerable shift.
** A solution : have the company defend the shares, release clinical data or updates.
Take action to increase current share price before presenting a R/S.
Explain further why the the numerous warrent and share awarding.
For those who want to jump on a inquiry and mildly attempt to silence a legitimate poster, don't bother as you are recognized as a board nazi.
First post, two years here, 280k shares. As shareholders we ought to be concerned with massive dilution via warrents at a pitiful exercise price and this chatter of reverse splits of 1/ 10 or 1-25. The noise of this achieving up listing is nonsense without the following. TPIV senior management are key in any value increase by means of P/1 latest results, updated status of P/2, and other positive news.
Other than dilution, nothing has been forth coming for far to long.
S/P erosion takes place, nerves get tested, and decisions to sell and salvage capital begin.
I'd like to hear a lot from the company. I 'd like to hear more of the science from TP, Rk, Blu, and Phantom.
For too many months now, this board is filled with wasted thoughts and nonsense speculation .
Maybe a bit harsh, but none the less true.
Flem, This continues to be good work by you and it is appreciated. I think many read, but do not post. A difference I think is that at R.B. controversy is evident, while this board has facts and data. Thanks again, as this thread is very much needed. Your friend of years, Gatta.
Flem...looks clean around here, 09/22/2006. I hope that others will come here and post. What kinds of postings do you hope to read here?
Thanks............. Gatta...